Roche Holding AG
RO
Rank in Stocks
#43
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Share Price
$499.93
Market Cap
$340.15B
Change (1 day)
-0.05%
Change (1 year)
34.04%
Country
CH
Trade Roche Holding AG (RO)
Category
Healthcare
EPS for Roche Holding AG (RO)
EPS as of December 2025 TTM: $20.39
According to Roche Holding AG latest financial reports and stock price the company's current EPS (TTM) is $20.39. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Roche Holding AG from 2026 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $29.89 | 46.60% |
US
|
|
| $6.60 | -67.63% |
US
|
|
| $3.55 | -82.59% |
US
|
|
| $1.26 | -93.82% |
US
|
|
| $7.19 | -64.74% |
CH
|
